Data coverage, completeness and provenance for ACRUX LIMITED in the Stock Market API — Health Care · Biotechnology.
Source date: 2026-10-30T04:08:22. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 0.0100 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 0.0100 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 0.0100 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 0.0100 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.0100 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/ACR/prices · Price parameters and adjustment semantics
Acrux Limited, together with its subsidiaries, develops and commercializes topically applied pharmaceutical products in Australia, the United States, Europe, and internationally. The company offers Dapsone 7.5% and 5% gels for the treatment of acne vulgaris; Nitroglycerine 0.4% ointments for the treatment of moderate to severe pain associated with chronic anal fissure; Lidocaine and Prilocaine creams USP 2.5% for local analgesia and pre-treatment for infiltration anesthesia; and estradiol transdermal sprays for women for the treatment of moderate to severe hot flushes associated with menopause under the Lenzetto and Evamist brand names. It also provides laboratory and product development services, including in vitro release testing; formulation development; stability and quality check; analytical; generic and pharma development; regulatory; project management and technology transfer; consulting; and co-development services. The company was incorporated in 1998 and is based in West Melbourne, Australia.
Website: https://acrux.com.au · Profile fields populated: 60%
Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/ACR/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 (AUD) | 2026-06-30 | 28 | yfinance | ||||
| FY2025 (AUD) | 2025-06-30 | 29 | yfinance | ||||
| FY2024 (AUD) | 2024-06-30 | 28 | yfinance | ||||
| FY2023 (AUD) | 2023-06-30 | 28 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/ACR
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/ACR/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/ACR/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/ACR/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/ACR/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/ACR
Free tier — instant API key. Built for AI agents.